You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplastic Syndromes

Showing 1 - 25 of 3,174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

Recruiting
  • Myelodysplastic Syndromes
  • IV Decitabine
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

Recruiting
  • Myelodysplastic Syndromes
  • Blood test
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 27, 2023

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Anemia Trial (Luspatercept)

Not yet recruiting
  • Anemia
  • Luspatercept
  • (no location specified)
May 26, 2023

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • High-Risk and Very High-Risk Myelodysplastic Syndromes
    • (no location specified)
    Jul 25, 2023

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

    Not yet recruiting
    • Myeloid Malignancy
    • +4 more
    • Telehealth Serious Illness Care Program
    • Education Control
    • Rochester, New York
      University of Rochester
    May 24, 2023

    Based on Quantitative Pharmacology in Patients With Lenalidomide

    Recruiting
    • Multiple Myeloma
    • +2 more
      • Jinan, Shandong, China
        the First Affiliated Hospital of Shandong First Medical Universi
      Oct 3, 2023

      Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Sep 18, 2023

      MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

      Recruiting
      • Myelodysplastic Syndromes
      • Chronic Myelomonocytic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital, Chinese Acade
      Jul 30, 2023

      MDS Trial (Roxadustat in combination with retinoic acid)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Roxadustat in combination with retinoic acid
      • (no location specified)
      Aug 26, 2023